Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 10,988 | 8,443 | 4,057 | 3,285 | 15,633 |
| Gross Profit | 10,988 | 8,443 | 4,057 | 3,285 | 15,633 |
| Operating Expenses | 18,445 | 19,442 | 23,069 | 20,046 | 20,692 |
| Operating Income | -7,457 | -10,999 | -19,012 | -16,761 | -5,059 |
| Interest Expense | 0 | 0 | 0 | 0 | -3 |
| Other Income | 2,356 | 1,467 | 2,476 | 1,263 | 884 |
| Pre-tax Income | -5,101 | -9,532 | -16,536 | -15,498 | -4,172 |
| Net Income Continuous | -5,101 | -9,532 | -16,536 | -15,498 | -4,172 |
| Net Income | $-5,101 | $-9,532 | $-16,536 | $-15,498 | $-4,172 |
| EPS Basic Total Ops | -5.60 | -12.00 | -19.20 | -20.00 | -5.60 |
| EPS Basic Continuous Ops | -5.54 | -11.20 | -19.53 | -20.03 | -5.93 |
| EPS Diluted Total Ops | -5.60 | -12.00 | -19.20 | -20.00 | -5.60 |
| EPS Diluted Continuous Ops | -5.54 | -11.20 | -19.53 | -20.03 | -5.93 |
| EBITDA(a) | $-6,612 | $-10,390 | $-18,404 | $-16,144 | $-4,434 |